Loading
No insider purchase over the last 90 days. The latest was filed 13 May 2026.
Hannover Rück SE: what insiders have been doing
Hannover Rück SE, classified in the Banks sector, is a listed company based in Hanover, Germany, founded in 1966. Its insiders report their share dealings to BaFin. Over the twelve months to 18 October 2026, the company's managers filed 2 filings, from 2 insiders.
Every open-market trade in the period is a purchase: 2 purchases worth €330k, from 2 insiders, and not a single sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The largest single trade was a purchase of €234k by Jungsthöfel, Clemens, published on 13 May 2026, equal to 0.0008% of the market capitalisation. On the buying side, the filings list 2 senior executives among the declarants.
The clock since the last published purchase (13 May 2026) now reads 157 days.
Compared with its exchange (287 companies, median 5 filings), a count of 2 filings is below the norm. Over the whole record (from 2026), the tally stands at 2 purchases and no sales.
Elsewhere in the same sector, our signals recently picked up insider purchases at First Guaranty Bancshares, Inc. and BCB Bancorp Inc. Source: insider filings from BaFin. Past trades are no guide to future returns.
Insider Decl.
2
Thresholds
n/a
Buy Volume
€329,760
2 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleClemens Jungsthöfel3 buys
Since the insiders bought
- +15.6%Entry €237.40 · Close 16 Oct 2026 €274.40
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Hannover Rück SE Buy (bullish), based on 15 analysts. Average price target: €282.47.
Fundamental score
Ranked 1,967 of 24,148 companies
75.5
score / 100
Value76
Quality75
FCF yld18%
Earn yld8.5%
EV/EBITDA10.2x
ROE22%
Gross mgn·
Net mgn11%
Debt/EBITDA1.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
€258.20
Analyst consensus
15 analystsBuy
€247.00Target €282.47(+9%)€360.00
Income statement
Revenue€24.0B
EBITDA€3.4B14% margin
Net income€2.6B12.1% margin
Valuation
PER (trailing)11.4x
PER (forward)10.9x
P/Book2.3x
Beta0.12
Balance sheet & cash
Market cap€31.1B
Total debt€4.1B
Free Cash Flow€5.7B
Debt / Equity29%
Profitability & ownership
ROE22.2%
ROA2.9%
% insiders50.2%
% institutions29.2%
Last declaration on 13 May 2026
Declarations2 total
1,000 shares@ €234.000.0008% mcap71.0% of flowShareXetra, Frankfurter WertpapierbörseISIN DE0008402215BAFIN:40001452-c38b045fb85a
Canonical exit: 10 Aug 2026 (T+90)
400 shares@ €239.4029.0% of flowShareXetra, Frankfurter WertpapierbörseISIN DE0008402215BAFIN:40001452
Canonical exit: 21 Apr 2026 (T+90)
2 of 2 declarations
About Hannover Rück SE
Hannover Rück SE (Hannover Re) is a global reinsurance group listed on Xetra/Frankfurt (DAX/MDAX/SDAX) in Germany. Founded in 1966 and listed in 1994, the company has built a long-standing international franchise centered on underwriting discipline, capital management, and geographic diversification. Its headquarters are in Hannover, Germany, at Karl-Wiechert-Allee 50, 30625 Hannover, and the group operates worldwide across all continents. ([hannover-re.com](https://www.hannover-re.com/en/group/about-hannover-re/history/?utm_source=openai))
The business is organized around two core segments: property & casualty reinsurance and life & health reinsurance. In property & casualty, Hannover Re covers a broad range of risks including property, natural catastrophes, specialty lines, energy, engineering, agriculture, and tailored solutions for cedants. In life & health, the group provides reinsurance for life insurance, health insurance, annuities, and personal accident business, alongside financial reinsurance and product partnership solutions. This dual-segment model gives Hannover Re exposure to distinct risk pools while reducing dependence on any single line of business. ([hannover-re.com](https://www.hannover-re.com/en/group/about-hannover-re/business/?utm_source=openai))
Read moreShow less
From a competitive standpoint, Hannover Re is widely regarded as one of the world’s leading professional reinsurers. Its strengths lie in a broad global footprint, strong local market knowledge, centralized risk steering, and the ability to deliver both standard treaty capacity and highly customized solutions. The company also emphasizes lean structures and disciplined capital deployment, which support profitability across the underwriting cycle. That combination has helped Hannover Re preserve attractive returns even in more competitive market conditions, while keeping the business model diversified between P&C and life & health. ([hannover-re.com](https://www.hannover-re.com/en/group/about-hannover-re/business/?utm_source=openai))
Recent developments underline the strength of the franchise. In March 2026, Hannover Re reported full-year 2025 net income of EUR 2.6 billion, up 13.4%, and proposed a dividend of EUR 12.50 per share, while confirming guidance for at least EUR 2.7 billion of net income in 2026. In May 2026, the company reported a strong first quarter, with materially higher profit and meaningful premium growth in April renewals. Management also highlighted improved reserve resilience, a strong solvency position, and returns on equity well above the strategic target. For investors, Hannover Re remains a high-quality reinsurance name with an attractive defensive profile, although earnings remain exposed to large-loss events, pricing dynamics, and financial market conditions. ([hannover-re.com](https://www.hannover-re.com/de/news/2026/hannover-rueck-steigert-gewinn-und-dividende-und-staerkt-nachhaltige-ertragskraft-signifikant/?utm_source=openai))
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
